The FDA has cleared its first artificial intelligence-powered device that checks out suspicious moles, bumps or lesions for the signs of skin cancer, with a handheld probe developed by DermaSensor.
In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...
Experts recommend checking skin, breasts, and testicles regularly for lumps or growths. Finding cancer early can improve treatment and outcomes. In addition to getting routine screenings recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback